PT3157549T - Nova imunoterapia contra vários tumores do sangue, em particular a leucemia linfoide crónica (llc) - Google Patents
Nova imunoterapia contra vários tumores do sangue, em particular a leucemia linfoide crónica (llc)Info
- Publication number
- PT3157549T PT3157549T PT157301359T PT15730135T PT3157549T PT 3157549 T PT3157549 T PT 3157549T PT 157301359 T PT157301359 T PT 157301359T PT 15730135 T PT15730135 T PT 15730135T PT 3157549 T PT3157549 T PT 3157549T
- Authority
- PT
- Portugal
- Prior art keywords
- cll
- blood
- lymphoid leukemia
- against several
- chronic lymphoid
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462014849P | 2014-06-20 | 2014-06-20 | |
| GBGB1411037.3A GB201411037D0 (en) | 2014-06-20 | 2014-06-20 | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3157549T true PT3157549T (pt) | 2020-07-01 |
Family
ID=51409910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT157301359T PT3157549T (pt) | 2014-06-20 | 2015-06-17 | Nova imunoterapia contra vários tumores do sangue, em particular a leucemia linfoide crónica (llc) |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP3157549B1 (pt) |
| JP (1) | JP6560261B2 (pt) |
| CA (1) | CA2950827A1 (pt) |
| DK (1) | DK3157549T3 (pt) |
| ES (1) | ES2802155T3 (pt) |
| GB (1) | GB201411037D0 (pt) |
| HU (1) | HUE050070T2 (pt) |
| LT (1) | LT3157549T (pt) |
| PL (1) | PL3157549T3 (pt) |
| PT (1) | PT3157549T (pt) |
| RS (1) | RS60592B1 (pt) |
| SI (1) | SI3157549T1 (pt) |
| TW (3) | TW201930347A (pt) |
| WO (1) | WO2015193359A2 (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201408255D0 (en) * | 2014-05-09 | 2014-06-25 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML) |
| IL259931B2 (en) | 2015-12-16 | 2024-02-01 | Gritstone Bio Inc | Identification of neo-antigens, preparation, and use |
| CN114028549A (zh) | 2016-02-19 | 2022-02-11 | 伊玛提克斯生物技术有限公司 | 用于nhl和其他癌症免疫治疗的新型肽和肽组合物 |
| GB201602918D0 (en) | 2016-02-19 | 2016-04-06 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers |
| GB201603987D0 (en) * | 2016-03-08 | 2016-04-20 | Immatics Biotechnologies Gmbh | Uterine cancer treatments |
| EA201892333A1 (ru) | 2016-04-21 | 2019-03-29 | Имматикс Байотекнолоджиз Гмбх | Иммунотерапия меланомы и других видов рака |
| CR20180551A (es) | 2016-04-21 | 2019-02-12 | Immatics Biotechnologies Gmbh | Inmunoterapia contra el melanoma y otros tipos de cáncer |
| DE102016005550A1 (de) | 2016-05-09 | 2017-11-09 | Emc Microcollections Gmbh | Adjuvans zur lnduzierung einer zellulären lmmunantwort |
| JP7075125B2 (ja) | 2016-05-25 | 2022-05-25 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ |
| GB201609193D0 (en) | 2016-05-25 | 2016-07-06 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers |
| CN107722114A (zh) * | 2016-07-07 | 2018-02-23 | 胡国田 | 一种多肽及其应用 |
| TW202304970A (zh) | 2016-08-26 | 2023-02-01 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| EP3609531A2 (en) | 2017-04-10 | 2020-02-19 | immatics biotechnologies GmbH | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers |
| WO2018189152A2 (en) * | 2017-04-10 | 2018-10-18 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers |
| AU2018348165A1 (en) | 2017-10-10 | 2020-05-21 | Gritstone Bio, Inc. | Neoantigen identification using hotspots |
| KR20200090855A (ko) | 2017-11-22 | 2020-07-29 | 그릿스톤 온콜로지, 인코포레이티드 | 신생항원에 대한 접합 에피토프 제시 감소 |
| DE102018107224A1 (de) | 2018-02-21 | 2019-08-22 | Immatics Biotechnologies Gmbh | Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten |
| US10925947B2 (en) | 2018-06-29 | 2021-02-23 | Immatics Biotechnologies Gmbh | A*03 restricted peptides for use in immunotherapy against cancers and related methods |
| TW202019955A (zh) * | 2018-07-31 | 2020-06-01 | 德商英麥提克生物技術股份有限公司 | B*07 限制肽和肽組合的抗癌免疫治療和相關方法 |
| WO2020035123A1 (en) * | 2018-08-11 | 2020-02-20 | Baerlecken Niklas | Autoantibodies binding to negative elongation factor e (nelf-e) for diagnosing sarcoidosis |
| CN109593125A (zh) * | 2018-12-12 | 2019-04-09 | 深圳市龙华区人民医院 | 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p1及其应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| ES8105035A1 (es) | 1978-12-22 | 1981-05-16 | Biogen Nv | Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| US4897445A (en) | 1986-06-27 | 1990-01-30 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide bond |
| ES2138662T3 (es) | 1993-06-03 | 2000-01-16 | Therapeutic Antibodies Inc | Produccion de fragmentos de anticuerpos. |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| DE69723230T2 (de) | 1996-01-17 | 2004-05-27 | Imperial College Innovations Ltd. | Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl) |
| US5849589A (en) | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US20040191260A1 (en) | 2003-03-26 | 2004-09-30 | Technion Research & Development Foundation Ltd. | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof |
| IL151860A0 (en) | 2000-03-27 | 2003-04-10 | Technion Res & Dev Foundation | Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same |
| WO2001093913A2 (en) | 2000-06-05 | 2001-12-13 | Sunol Molecular Corporation | T cell receptor fusions and conjugates and methods of use thereof |
| WO2002040668A2 (de) * | 2000-11-15 | 2002-05-23 | Apoxis Sa | Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen |
| US7919467B2 (en) * | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| US6992176B2 (en) | 2002-02-13 | 2006-01-31 | Technion Research & Development Foundation Ltd. | Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| JP2005533486A (ja) | 2002-02-20 | 2005-11-10 | ダイアックス、コープ | Ｍｈｃ−ペプチド複合体結合リガンド |
| US7569664B2 (en) | 2002-10-09 | 2009-08-04 | Immunocore Limited | Single chain recombinant T cell receptors |
| ATE432290T1 (de) | 2002-11-09 | 2009-06-15 | Immunocore Ltd | T ZELL REZEPTOR ßDISPLAYß |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| EP2302394A1 (en) * | 2004-05-21 | 2011-03-30 | The Institute for Systems Biology | Compositions and methods for quantification of serum glycoproteins |
| PT1806359E (pt) | 2005-09-05 | 2010-05-25 | Immatics Biotechnologies Gmbh | Peptídeos associados a tumor ligando promiscuamente às moléculas do antigénio de leucócitos humanos (hla) da classe ii |
| US20070248628A1 (en) * | 2005-12-06 | 2007-10-25 | Keller Lorraine H | Immunogens in cancer stem cells |
| US20090263574A1 (en) | 2008-04-21 | 2009-10-22 | Quinn Daniel E | Method of restoring an article |
| GB201006360D0 (en) | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| BR112013010213A2 (pt) | 2010-10-26 | 2019-09-24 | Technion Research & Development Foundation Ltd | anticorpos que unem ligantes solúveis de receptores de célula t |
| WO2013057586A1 (en) | 2011-10-19 | 2013-04-25 | Oslo Universitetssykehus Hf | Compositions and methods for producing soluble t - cell receptors |
-
2014
- 2014-06-20 GB GBGB1411037.3A patent/GB201411037D0/en not_active Ceased
-
2015
- 2015-06-17 EP EP15730135.9A patent/EP3157549B1/en active Active
- 2015-06-17 WO PCT/EP2015/063566 patent/WO2015193359A2/en active Application Filing
- 2015-06-17 SI SI201531301T patent/SI3157549T1/sl unknown
- 2015-06-17 RS RS20200910A patent/RS60592B1/sr unknown
- 2015-06-17 JP JP2016572509A patent/JP6560261B2/ja not_active Expired - Fee Related
- 2015-06-17 DK DK15730135.9T patent/DK3157549T3/da active
- 2015-06-17 ES ES15730135T patent/ES2802155T3/es active Active
- 2015-06-17 CA CA2950827A patent/CA2950827A1/en not_active Abandoned
- 2015-06-17 HU HUE15730135A patent/HUE050070T2/hu unknown
- 2015-06-17 PT PT157301359T patent/PT3157549T/pt unknown
- 2015-06-17 PL PL15730135T patent/PL3157549T3/pl unknown
- 2015-06-17 EP EP20170980.5A patent/EP3708185A3/en not_active Withdrawn
- 2015-06-17 LT LTEP15730135.9T patent/LT3157549T/lt unknown
- 2015-06-18 TW TW108109176A patent/TW201930347A/zh unknown
- 2015-06-18 TW TW109104580A patent/TW202024125A/zh unknown
- 2015-06-18 TW TW104119833A patent/TWI670282B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUE050070T2 (hu) | 2020-11-30 |
| RS60592B1 (sr) | 2020-08-31 |
| GB201411037D0 (en) | 2014-08-06 |
| PL3157549T3 (pl) | 2020-12-14 |
| TW201613956A (en) | 2016-04-16 |
| TW201930347A (zh) | 2019-08-01 |
| JP2017525336A (ja) | 2017-09-07 |
| EP3157549B1 (en) | 2020-04-29 |
| EP3157549A2 (en) | 2017-04-26 |
| WO2015193359A2 (en) | 2015-12-23 |
| WO2015193359A3 (en) | 2016-02-25 |
| DK3157549T3 (da) | 2020-06-22 |
| EP3708185A3 (en) | 2020-11-04 |
| SI3157549T1 (sl) | 2020-08-31 |
| TW202024125A (zh) | 2020-07-01 |
| CA2950827A1 (en) | 2015-12-23 |
| EP3708185A2 (en) | 2020-09-16 |
| TWI670282B (zh) | 2019-09-01 |
| JP6560261B2 (ja) | 2019-08-14 |
| ES2802155T3 (es) | 2021-01-15 |
| LT3157549T (lt) | 2020-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE050070T2 (hu) | Új immunterápia többféle vérképzõszervi daganat, különösen krónikus limfoid leukémia (CLL) ellen | |
| DK3140319T3 (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml) | |
| HK1222121A1 (zh) | 用於治療多種腫瘤 例如包括 在內的肺癌 的新型免疫療法 | |
| EP3094342A4 (en) | Anti-tumor therapy | |
| IL280565A (en) | New immunotherapy against various tumors such as lung cancer which includes nsclc | |
| EP3157553A4 (en) | Treatment for chronic lymphocytic leukemia (cll) | |
| IL271367A (en) | Innovative immunotherapy against blood tumors such as acute leukemia in the spinal cord | |
| IL249533A0 (en) | Treatment of chronic lymphocytic leukemia | |
| GB201403297D0 (en) | Novel immunotherapy against several tumors, such as lung cancer, including NSCLC | |
| GB201313987D0 (en) | Novel immunotherapy against several tumors, such as lung cancer including NSCLC |